INmune Bio (NasdaqCM:INMB) Q4 2025 Earnings call March 30, 2026 04:30 PM ET Speaker6Greetings, and welcome to the INmune Bio's 2025 fourth quarter and year-end earnings call. As a reminder, this conference is being recorded. A transcript will follow within 24 hours of this conference call. At this time, it is now my pleasure to introduce Mr. Daniel Carlson, Head of Investor Relations of INmune Bio. Daniel.Speaker2Thank you, Chloe, and good afternoon, everyone. We thank you for joining us on the call for INm ...